Skip to main content
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. — Investor Relations & Filings

Ticker · VYGR ISIN · US92915B1061 LEI · 54930082S4XVR0ZWCC74 US Manufacturing
Filings indexed 621 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US VYGR

About Voyager Therapeutics, Inc.

https://www.voyagertherapeutics.com/

Voyager Therapeutics, Inc. is a biotechnology company that develops genetic medicines for severe neurological diseases. Its pipeline includes therapeutic programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and other diseases of the central nervous system. The company utilizes its proprietary TRACER™ AAV capsid discovery platform, which generates novel adeno-associated virus (AAV) capsids designed to effectively cross the blood-brain barrier. This technology aims to enable targeted delivery of genetic therapies to the brain and spinal cord through intravenous administration.

Recent filings

Filing Released Lang Actions
10-Q - Voyager Therapeutics, Inc. (0001640266) (Filer)
Interim / Quarterly Report
2026-05-07 English
SCHEDULE 13G/A - Voyager Therapeutics, Inc. (0001640266) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - VOYAGER THERAPEUTICS, INC. (0001640266) (Filer)
Director's Dealing
2026-02-26 English
4 - VOYAGER THERAPEUTICS, INC. (0001640266) (Filer)
Director's Dealing
2026-02-26 English
4 - VOYAGER THERAPEUTICS, INC. (0001640266) (Filer)
Director's Dealing
2026-02-26 English
4 - VOYAGER THERAPEUTICS, INC. (0001640266) (Filer)
Director's Dealing
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.